These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis. Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M. J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346 [Abstract] [Full Text] [Related]
3. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A. Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883 [Abstract] [Full Text] [Related]
4. Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression. Perlis RH, Adams DH, Fijal B, Sutton VK, Farmen M, Breier A, Houston JP. J Clin Psychiatry; 2010 May; 71(5):599-605. PubMed ID: 20021991 [Abstract] [Full Text] [Related]
6. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial. Detke HC, DelBello MP, Landry J, Usher RW. J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):217-24. PubMed ID: 25721187 [Abstract] [Full Text] [Related]
7. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial. Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, Ming L, Gaohua W, Xinbao Z, Huichun L, Liang S. J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327 [Abstract] [Full Text] [Related]
8. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. Brown EB, McElroy SL, Keck PE, Deldar A, Adams DH, Tohen M, Williamson DJ. J Clin Psychiatry; 2006 Jul; 67(7):1025-33. PubMed ID: 16889444 [Abstract] [Full Text] [Related]
9. Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials. Szegedi A, Zhao J, van Willigenburg A, Nations KR, Mackle M, Panagides J. BMC Psychiatry; 2011 Jun 20; 11():101. PubMed ID: 21689438 [Abstract] [Full Text] [Related]
10. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression. Corya SA, Perlis RH, Keck PE, Lin DY, Case MG, Williamson DJ, Tohen MF. J Clin Psychiatry; 2006 May 20; 67(5):798-806. PubMed ID: 16841630 [Abstract] [Full Text] [Related]
14. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data. Suppes T, Brown E, Schuh LM, Baker RW, Tohen M. J Affect Disord; 2005 Dec 20; 89(1-3):69-77. PubMed ID: 16253344 [Abstract] [Full Text] [Related]
16. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM). Vieta E, Angst J, Reed C, Bertsch J, Haro JM, EMBLEM advisory board. J Affect Disord; 2009 Nov 20; 118(1-3):118-23. PubMed ID: 19269690 [Abstract] [Full Text] [Related]